- Home
- JELD vs QSI Comparison
JELD vs QSI Comparison
Compare JELD & QSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | JELD | QSI |
|---|---|---|
| Founded | 1960 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Forest Products | Biotechnology: Pharmaceutical Preparations |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 152.7M | 165.6M |
| IPO Year | 2016 | 2020 |
Fundamental Metrics
Financial Performance| Metric | JELD | QSI |
|---|---|---|
| Price | $1.38 | $1.33 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 3 | 3 |
| Target Price | $1.93 | ★ $2.30 |
| AVG Volume (30 Days) | 1.6M | ★ 8.1M |
| Earning Date | 11-02-2026 | 11-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 28.17 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $3,211,181,000.00 | $2,436,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $2.28 | $406.32 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.93 | $0.69 |
| 52 Week High | $4.92 | $2.73 |
Technical Indicators
Market Signals| Indicator | JELD | QSI |
|---|---|---|
| Relative Strength Index (RSI) | 36.20 | 59.85 |
| Support Level | $1.31 | $0.81 |
| Resistance Level | $2.18 | $1.32 |
| Average True Range (ATR) | 0.17 | 0.17 |
| MACD | -0.05 | 0.03 |
| Stochastic Oscillator | 13.94 | 60.99 |
Price Performance
Historical ComparisonAbout JELD JELD-WEN Holding Inc.
JELD-WEN Holding Inc is engaged in door and window manufacturing. The company designs, produces, and distributes interior and exterior building products, offering a selection of doors, windows, walls, and related products. The products are used in the new construction of residential and non-residential buildings. The firm's operating segments are North America, and Europe. It generates a majority of its revenue from North America.
About QSI Quantum-Si Incorporated
Quantum-Si Inc is a life sciences company focused on proteomics research and analytical technologies. It develops single-molecule detection platforms designed to enable next-generation protein sequencing (NGPS) and large-scale protein analysis. Its technology supports massively parallel sequencing of proteins and can also be applied to the study of nucleic acids, providing tools for researchers and clinical applications in molecular analysis. The company's revenue is derived from sales of products and services.